About Somerset Therapeutics Private Limited
Data last updated:
Somerset Therapeutics Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Veego Pharma Llc. It operates in the chemical products segment of the chemicals sector. It was incorporated on 23 August 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85110KA1990PTC011166. Its GSTIN is 29AAACR8613H1Z8 (Karnataka).
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹31.6 Cr. It was formerly known as Recon Pharma Private Limited and Wint Ac Limited. It is led by directors including Karupannan Poongudi Murali (Whole-Time Director) and Ramasamy Anbarasi Thirumoorti.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 54/1 / 54/2 Boodihal Village Nelamangala, Bangalore, Karnataka, India – 562123.
As per the financials filed for FY 2025, the company reported a revenue of ₹297.65 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹38.4 Cr (net margin 12.9%) and EBITDA of ₹55.11 Cr (EBITDA margin 18.5%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 28% over five years.
The company has about 620 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹58.06 Cr on record. Court records list 68 cases involving the company, including 30 filed by the company and 38 filed against it; 10 cases are pending. The company has 11 deals on record (9 market trades, 2 acquisitions); the latest was in March 2016. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Zeiss Pharma Limited with revenue of ₹310.78 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 4 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website somersetlimited.com.
Company details
Name history
Somerset Therapeutics has undergone 6 name changes throughout its history. The current legal name is Somerset Therapeutics Private Limited.
| Company Name | Status |
|---|---|
| Somerset Therapeutics Private Limited | Current |
| Recon Pharma Private Limited | Previous |
| Wint Ac Limited | Previous |
| Recon Limited | Previous |
| Wintac Limited | Previous |
| Recon Pvt Ltd | Previous |
| Recon Pharma Pvt Ltd | Previous |
CIN history
Somerset Therapeutics has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U85110KA1990PTC011166, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110KA1990PTC011166 | Current |
| L85110KA1990PLC011166 | Previous |
| U85110KA1990PLC011166 | Previous |
| U02411KA1990PLC011166 | Previous |
Contact details
Somerset Therapeutics Private Limited's registered office is in Bangalore, Karnataka. Its website is somersetlimited.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address54/1 / 54/2 Boodihal Village Nelamangala, Bangalore, Karnataka, India – 562123
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Somerset Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Somerset Therapeutics are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Somerset Therapeutics Private Limited, buy the company report.
Financials of Somerset Therapeutics Private Limited
FY 2025 filings availableSomerset Therapeutics Private Limited reported revenue of ₹297.65 Cr (up 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 35% growth in the latest year. EBITDA rose 154% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.5% | ||||
| Net Profit Margin | 12.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Somerset Therapeutics Private Limited, buy the company report.
Board of directors of Somerset Therapeutics Private Limited
Somerset Therapeutics has 5 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karupannan Poongudi Murali | Whole-Time Director | 01 Jan 2021 | 5 Years 10 Months | Current |
| Ramasamy Anbarasi Thirumoorti | Director | 23 May 2018 | 8 Years 5 Months | Current |
| Kannilakshmaniyer Krishnamachary Paranjyothi Also directs: Yashaha Laboratories Private Limited | Director | 27 Jul 2017 | 9 Years 3 Months | Current |
| Mohanambal Paramasivam Gounder | Director | 27 Nov 2024 | 1 Years 11 Months | Current |
| Velusamy Jaiashokan | Director | 27 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Somerset Therapeutics Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zeiss Pharma Limited | ₹310.78 Cr (FY 2025) | 13.0% | Panchkula, Haryana, India | |||
| Ultra Drugs Private Limited | ₹308.31 Cr (FY 2024) | 24.0% | Chandigarh, India | |||
| Ciron Drugs and Pharmaceuticals Private Limited | ₹304.93 Cr (FY 2024) | 15.0% | Mumbai, Maharashtra, India | |||
| Aagya Biotech Private Limited | ₹298.87 Cr (FY 2024) | -8.0% | Roorkee, Uttarakhand, India | |||
| Somerset Therapeutics Private Limitedthis company | ₹297.65 Cr (FY 2025) | ₹38.4 Cr | 12.9% | 35.0% | 620 | Bangalore, Karnataka, India |
| Biomatrix Healthcare Private Limited | ₹295.64 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Globela Pharma Private Limited | ₹295.59 Cr (FY 2025) | 13.0% | Surat, Gujarat, India | |||
| Ravenbhel Health Care Private Limited | ₹290.95 Cr (FY 2025) | 16.0% | Jammu, Jammu and Kashmir, India | |||
| Agio Pharmaceuticals Limited | ₹287.95 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Somerset Therapeutics Private Limited, buy the company report.
Auditor
Somerset Therapeutics Private Limited is audited by B. K. RAMADHYANI & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. K. RAMADHYANI & CO LLP | FY 2023 | 002878S/S200021 |
Shareholding
The shareholding of Somerset Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Somerset Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Feb 2024 | 100880237 | Hdfc Bank Limited | ₹30 Cr | Open | |
| 23 Feb 2022 | 100546665 | State Bank of India | ₹10 Cr | Satisfied | |
| 20 Apr 2015 | 10566796 | State Bank of India | ₹10 Cr | Satisfied | |
| 29 Mar 2010 | 10217226 | State Bank of India | ₹17.96 Cr | Satisfied | |
| 09 Apr 2007 | 10051132 | Uco Bank | ₹7.9 Cr | Satisfied |
To see the full charge records of Somerset Therapeutics Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Somerset Therapeutics Private Limited has 11 deals on record (9 market trades, 2 acquisitions); the latest was in March 2016.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2014 | Acquisition | ₹1.05 Cr | Buyer: Bangalore Pharmaceutical and Research Laboratory Private Limited Seller: Somerset Therapeutics Private Limited |
| May 2013 | Market trade | ₹96.6 Lakh | Buyer: an individual Seller: Synergia Consultants Private Limited |
| May 2013 | Market trade | ₹2 Cr | Buyer: an individual Seller: Synergia Consultants Private Limited |
| May 2013 | Market trade | ₹1.5 Cr | Buyer: an individual Seller: Synergia Consultants Private Limited |
| Feb 2013 | Market trade | ₹70.3 Lakh | Buyer: an individual Seller: Synergia Consultants Private Limited |
To see the full deal history of Somerset Therapeutics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Somerset Therapeutics Private Limited has 68 court cases on record: 30 filed by Somerset Therapeutics, 38 filed against it. 10 cases are pending and 58 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 45 | 21 | 5 |
| District courts | 21 | 16 | 5 |
| Supreme Court | 2 | 1 | 0 |
Cases on record (5 of 68)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed against the company by Kemwell Biopharma Private Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ms Shalimar Paints Ltd. | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Serum Institute of India Private Ltd. | Pending |
| Bombay High Court | Court case (CHSCD) | Filed against the company by Serum Institute of India Ltd. | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by Laurus Labs Pvt Ltd | Disposed |
To see the full case history of Somerset Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Somerset Therapeutics Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Printmann Offset Private Limited CN | |||
| Amul Polymers | |||
| Klenzaids Contamination Controls (P) Ltd | |||
| Kitten Enterprises Private Limited |
To see the full MSME payment records of Somerset Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Somerset Therapeutics Private Limited has a workforce of 620 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.
GST
Somerset Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACR8613H1Z8 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Somerset Therapeutics Private Limited, buy the company report.
Recent activity
Somerset Therapeutics Private Limited has 18 board changes on record since 2010: 5 appointments and 13 cessations. The latest: Mohanambal Paramasivam Gounder was appointed as Director on 27 Nov 2024.
27 earlier events are in the company report.
Frequently asked questions
Somerset Therapeutics is an active private limited company based in Bangalore, Karnataka, India. The company works in chemical products, within the chemicals industry. It was incorporated on 23 August 1990 (36+ years old) and is registered under CIN U85110KA1990PTC011166.
Somerset Therapeutics has 5 current directors:
- Karupannan Poongudi Murali - Whole-Time Director
- Ramasamy Anbarasi Thirumoorti - Director
- Kannilakshmaniyer Krishnamachary Paranjyothi - Director
- Mohanambal Paramasivam Gounder - Director
- Velusamy Jaiashokan - Director
The latest financial statements of Somerset Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Somerset Therapeutics is 29AAACR8613H1Z8, registered in Karnataka.
The CIN (Corporate Identification Number) of Somerset Therapeutics is U85110KA1990PTC011166. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Somerset Therapeutics has 68 court cases on record: 30 filed by the company and 38 filed against it. 10 are pending. Most are in the high courts.
Somerset Therapeutics was incorporated on 23 August 1990, making it 36+ years old. It is registered with the Registrar of Companies, Bangalore.
Somerset Therapeutics has 11 deals on record (9 market trades, 2 acquisitions); the latest was in March 2016.
The peers of Somerset Therapeutics by revenue are Zeiss Pharma Limited, Ultra Drugs Private Limited, Ciron Drugs and Pharmaceuticals Private Limited, Aagya Biotech Private Limited, Biomatrix Healthcare Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mohanambal Paramasivam Gounder was appointed as Director on 27 Nov 2024. Velusamy Jaiashokan was appointed as Director on 27 Nov 2024. Nanthitha Shanmuhasundaram ceased to be Additional Director on 09 Jul 2021. Somerset Therapeutics has 18 board changes on record in total.
Somerset Therapeutics has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 4 micro and small suppliers. The latest return was filed on 04 Jun 2019.
Somerset Therapeutics can be reached through the website somersetlimited.com. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
